Banco Bilbao Vizcaya Argentaria, S.A. Catalent, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $8.53 Billion
- Q3 2024
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Catalent, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 5,643 shares of CTLT stock, worth $358,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,643Holding current value
$358,217% of portfolio
0.0%Shares
17 transactions
Others Institutions Holding CTLT
# of Institutions
216Shares Held
73.2MCall Options Held
477KPut Options Held
2.02M-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$473 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl4MShares$254 Million1.29% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.63MShares$230 Million0.38% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...